Papaverine: Clinical Trials

2 trials of Papaverine, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 unknown. 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 22Completed 1, Unknown 1

Follow Papaverine: new trials by email Literature Review of Papaverine trials Research Report on Papaverine

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
The Efficacy of Papaverine to Prevent Radial Artery Spasm During Transradial Cerebral Angiography
Papaverine Hydrochloride, normal saline - Radial Artery Spasm
Phase 2UnknownSun Yat-Sen Memorial Hospital of Sun Yat-Sen University2402023-05-242023-06-12
Nerve-Sparing Radical Prostatectomy With or Without Nerve Grafting Followed by Standard Therapy for Erectile Dysfunction in Treating Patients With Localized Prostate Cancer
Alprostadil (E1), Papaverine, Phentolamine mesylate - Prostate Cancer
Phase 2CompletedM.D. Anderson Cancer Center1112001-08-012012-07-30

Conditions studied

Infertility (1)  ·  Postoperative Complications (1)  ·  Prostatic Neoplasms (1)  ·  Sexual Dysfunction, Physiological (1)  ·  Sexuality (1)

Sponsors

M.D. Anderson Cancer Center (1)  ·  Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University (1)

Countries

China (1)  ·  United States (1)

Top investigators

Christopher G. Wood, MD (1)  ·  Yamei Tang, PhD (1)

Results publications

PMID 18783876, PMID 40930776

NIH funding

P30CA016672 (1), P50CA090270 (1)